Plaintiffs’ Firms Step Up Marex Class-Action Push Before Dec. 8 Lead-Plaintiff Cutoff
The suits hinge on allegations from an August 5 short-seller report accusing Marex of using off-balance-sheet dealings to conceal losses.
Overview
- Rosen, Berger Montague, DJS Law Group, the Schall Law Firm, and Kahn Swick & Foti issued new notices inviting Marex investors to seek lead-plaintiff roles.
- The proposed class period spans May 16, 2024 through August 5, 2025, with motions for lead plaintiff due by December 8, 2025.
- Complaints reference a NINGI Research report alleging self-dealing OTC trades, inconsistent intercompany accounts, and opaque entities tied to nearly $1 billion in derivatives exposure.
- A case is pending in the Southern District of New York as Narayanan v. Marex Group PLC, et al., asserting violations of Exchange Act §§10(b), 20(a) and SEC Rule 10b-5.
- Marex shares fell 6.2% to $35.31 on heavy volume after the report, and notices stress that no class is certified and the allegations remain unproven.